Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) was the target of a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 1,180,000 shares, a decrease of 23.9% from the January 31st total of 1,550,000 shares. Based on an average daily trading volume, of 335,000 shares, the short-interest ratio is presently 3.5 days. Currently, 8.8% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Maxim Group boosted their price target on Sensus Healthcare from $12.00 to $14.00 and gave the company a "buy" rating in a research report on Friday, November 15th. Lake Street Capital began coverage on Sensus Healthcare in a report on Friday, January 31st. They issued a "buy" rating and a $18.00 target price on the stock. Finally, HC Wainwright increased their price target on Sensus Healthcare from $11.00 to $12.00 and gave the stock a "buy" rating in a report on Monday, February 10th.

Hedge Funds Weigh In On Sensus Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Squarepoint Ops LLC lifted its stake in shares of Sensus Healthcare by 175.5% in the fourth quarter. Squarepoint Ops LLC now owns 85,677 shares of the company's stock valued at $593,000 after purchasing an additional 54,576 shares during the period. Man Group plc lifted its position in shares of Sensus Healthcare by 34.0% during the 4th quarter. Man Group plc now owns 59,338 shares of the company's stock valued at $411,000 after acquiring an additional 15,059 shares during the period. OMERS ADMINISTRATION Corp purchased a new stake in shares of Sensus Healthcare during the 4th quarter worth approximately $381,000. Millennium Management LLC grew its holdings in shares of Sensus Healthcare by 256.6% in the 4th quarter. Millennium Management LLC now owns 85,329 shares of the company's stock worth $590,000 after acquiring an additional 61,403 shares during the period. Finally, BNP Paribas Financial Markets acquired a new stake in shares of Sensus Healthcare in the 4th quarter worth approximately $47,000. 25.30% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Sensus Healthcare Stock Performance

SRTS traded up $0.14 during trading on Friday, reaching $4.60. The company's stock had a trading volume of 138,206 shares, compared to its average volume of 380,686. The company has a market capitalization of $75.39 million, a price-to-earnings ratio of 11.50 and a beta of 1.28. The company's fifty day moving average price is $6.34 and its 200-day moving average price is $6.74. Sensus Healthcare has a 52-week low of $2.91 and a 52-week high of $9.33.

Sensus Healthcare (NASDAQ:SRTS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by ($0.01). Sensus Healthcare had a net margin of 15.90% and a return on equity of 12.60%. Equities analysts predict that Sensus Healthcare will post 0.32 earnings per share for the current year.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.